Twist Bioscience valuation
$104.78Change from previous close: −6.12%Absolute change: −$6.82
Valuation
The average price target of 12 analysts is $135.17.
Data as of November 15, 2026
Twist Bioscience compared with similar companies
Twist Bioscience's Price/book: 15.7, +64% against the median of a group of 9 similar companies (9.57).
| Metric | Twist Bioscience | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Price/book | 15.7 | 9.57 | 5.28 – 20.0 | Middle |
| Price/sales | 16.1 | 8.80 | 6.44 – 14.5 | High |
| Gross margin | 52.4% | 91.1% | 59.7% – 95.3% | Low |
| Operating margin | -28.8% | 11.5% | -27.0% – 24.5% | Low |
| Net margin | -28.3% | 0.0% | -12.9% – 15.4% | Low |
| ROE | -19.1% | 8.3% | -9.7% – 38.5% | Low |
| Debt/equity | 0.12 | 0.12 | 0.02 – 0.67 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $7.4B
- Enterprise value
- $6.81B
- P/E (trailing 12 months)
- -77.4
- Forward P/E
- -279.0
- EV/EBITDA
- -63.4
- EV/revenue
- 14.8
Profitability and growth
- ROA
- -9.4%
- ROIC
- -15.3%
- Revenue growth (year over year)
- 27.9%
- Earnings growth (year over year)
- -270.2%
Financial health
- Total cash
- $581.91M
- Total debt
- $109.99M
- Current ratio
- 5.86
- Quick ratio
- 5.18
Dividends
- Dividend yield
- 0.0%
Analysts and estimates
- Average price target
- $135.17
- Median price target
- $136.00
- High price target
- $190.00
- Low price target
- $45.00
- Analysts with a price target
- 12
- Consensus
- Buy
- Forward EPS
- -$0.40
- EPS estimate, current year
- -$0.27
Shares and trading
- Beta
- 2.22
- Average volume
- 2.45M
- Shares outstanding
- 66.3M
- Float
- 64.39M
- Institutional ownership
- 119.6%
- Insider ownership
- 1.2%
- Short interest (% of float)
- 18.7%
- Short ratio (days)
- 3.26
